	Leucine Aminopeptidase-Responsive Bioluminescent Probe for Point-of-Care Diagnosis of Pancreatic Cancer in Blood and Urine. Anal Chem Qiu X, Ma Q, Yang Y, Zheng B, Zhou B, Chen Y, Fu B, Shan Y, Wang X, Xiong H. PMID: 42227969 [PubMed - as supplied by publisher]
	Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid. J Surg Oncol Mills K, Berger CK, Taylor WR, Mahoney DW, Burger KN, Maheshwari K, Kipp BR, Delgado AM, Doering KA, Streich HM, Foote PH, Cleary SP, Grotz TE, Kendrick ML, Smoot RL, Starlinger PP, Thiels CA, Truty MJ, Warner SG, Kisiel JB, Majumder S. PMID: 42226556 [PubMed - as supplied by publisher]
	Nonlinear Modeling Reveals Novel Associations Between Genetically Predicted Protein Levels and Pancreatic Cancer Risk. Mol Carcinog Zhu J, Wu C, Moaven O, Yamazaki H, Wei Y, Dai B, Wu L. PMID: 42226484 [PubMed - as supplied by publisher]
	Skin Health in Oncology: Evidence-Based Skin Care for Cancer Patients. Oncologist Kaminsky A, Suhl S, Sacknovitz Y, Schwartz GK, Deverapalli S, Geskin LJ. PMID: 42225610 [PubMed - as supplied by publisher]
	From Bench to Bedside: The Path Toward Real-World Translation for Artificial Intelligence in Pancreatic Cancer Detection. Korean J Radiol Syailendra EA, Arshad H, Lopez-Ramirez F, Tixier F, Kawamoto S, Fishman EK, Chu LC. PMID: 42225574 [PubMed - in process]
	Six key elements for effective coordination in home-based care for older adults with cancer in Japan: A qualitative interview study. J Geriatr Oncol Matsuoka A, Ayata M, Tanno K, Ando Y, Umegaki H, Kanai F, Sasaki T, Suzuki M, Tanaka C, Tsubata Y, Terada T, Nagashima F, Majima Y, Yanagawa M, Yamanaka T, Yamamoto H, Yokoyama T, Shimazu T, Fujimori M. PMID: 42224989 [PubMed - as supplied by publisher]
	Advances in deciphering intratumoral versus peritumoral heterogeneity of infiltrating lymphocytes in pancreatic cancer: a spatial perspective. Transl Oncol Zhao K, Yang Q, Yan Y, Zhu J, Zheng S. PMID: 42224953 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Neoadjuvant Therapy for Invasive Intraductal Papillary Mucinous Neoplasms: a Comparative Study with Pancreatic Ductal Adenocarcinoma. Ann Surg Oncol Ishida H, Rodriguez Franco S, Franklin O, Fujiwara Y, Khomiak A, Balmaceda NB, Pellegrini R, Mungo B, Schulick RD, Del Chiaro M. PMID: 42223773 [PubMed - as supplied by publisher]
	Depression and increased cancer risk: a 10-year population-based cohort study. Soc Psychiatry Psychiatr Epidemiol Baek CH, Kim HJ, Son M, Kim HR, Kim SH, Kim HS. PMID: 42223651 [PubMed - as supplied by publisher]
	Expert Validation of an Artificial Intelligence-Enabled Trial Matching Solution Using Real-World Data From Patients With Cancer. JCO Oncol Pract Patel JN, Maher MC, Morris V, Sha W, Terry M, Wilson L, Yano R, Jongeneel P, Ahmed F, Subramanian CR, Zappas A, Singh P, Baxi S, Nikolic O, Mesa RA, Voorhees P, Farhangfar CJ, Butera P. PMID: 42223138 [PubMed - as supplied by publisher]
	Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer. N Engl J Med O'Reilly EM, Wainberg ZA, Hendifar AE, Borad MJ, Pietrantonio F, Pant S, Hammel P, Cremolini C, Manji GA, Oberstein PE, Garrido-Laguna I, Springfeld C, Azad NS, Ueno M, Chui SY, Zhang Y, Patel H, Lee Y, Salman Z, Wolpin BM, RASolute 302 Trial Investigators. PMID: 42223072 [PubMed - as supplied by publisher]
	Anti-Cancer Research Progress of Triptolide: Mechanisms of Action, Structural Modifications, Nanodelivery Systems and Clinical Challenges. Drug Des Devel Ther Li ZX, Zang L, Li YQ, Zhang M, Zhao DM, Han XY, Zhao JF, Ding CH, Liu WS. PMID: 42221354 [PubMed - indexed for MEDLINE]
	Polypharmacy in Elderly Patients Receiving First-Line Treatment for Pancreatic Adenocarcinoma: Analysis of Potential Drug-Drug Interactions and Outcome. Oncol Res Vecchia S, Chinelli R, Orcesi A, Citterio C, Riva A, Orlandi E. PMID: 42220431 [PubMed - indexed for MEDLINE]
	Pharmacogenomic profiling of the efficacy of gemcitabine monotherapy in metastatic pancreatic cancer: Subgroup analysis of the GENESECT study. Br J Clin Pharmacol Yokokawa T, Tsuji D, Hatori M, Kawakami K, Nakao M, Yano T, Arakawa Y, Matsuo K, Ohashi Y, Ozaka M, Sasahira N, Sakata Y, Kogure Y, Tamaki S, Wada A, Taki Y, Suzuki W, Kobayashi K, Ishii H, Itoh K, Yamaguchi M, Suzuki K. PMID: 42220058 [PubMed - as supplied by publisher]
	Non-ablative focused ultrasound induces an adaptive immune response to suppress pancreatic cancer: a preclinical study. Ultrasonography Park EJ, Ahn Y, Cheon Y, Lee JY. PMID: 42220052 [PubMed]
	Application of small interfering RNAs and drug combination for pancreatic cancer therapy. J Drug Target Zeng C, Chen SZ. PMID: 42219546 [PubMed - as supplied by publisher]
	Quantifying Weight Loss Prior to Pancreatic Cancer Diagnosis: A Systematic Review and Meta-Analysis. Cancer Med Price CA, Cooke D, Mold F, Smith NAS, Winn M, Lemanska A. PMID: 42219540 [PubMed - indexed for MEDLINE]
	Current advances in immunotherapy for KRAS-Mutant pancreatic cancer. Clin Exp Med Li M, Wang X, Li P, Gong H, Wu J, Mao Y. PMID: 42218726 [PubMed - as supplied by publisher]
	ASO Visual Abstract: Prognostic Value of Circulating Exosomal DNA in Esophageal Squamous Cell Carcinoma: A Prospective Cohort Study. Ann Surg Oncol Nakai T, Kitahata Y, Hiraki H, Nakamura Y, Motobayashi H, Takemoto N, Hyo T, Sato M, Ojima T, Hayata K, Goda T, Kitadani J, Tominaga S, Hayami S, Miyamoto A, Yamaue H, Iwaya T, Nishizuka S, Kawai M. PMID: 42218348 [PubMed - as supplied by publisher]
	RAD1 promotes oxaliplatin resistance in gastric cancer by reinforcing NRF2-driven antioxidant defense and DDR checkpoint signaling. Drug Resist Updat Zhou B, Zhang S, Shen Z, Si Y, Luo T, Shen H, Wei W, Yang Q, Duan M, Wang Z, Feng S, Xu A. PMID: 42217457 [PubMed - as supplied by publisher]

Articles 1 - 20 / 60277

Page 1 of 3014



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy